State-of-the-industry video lectures by leading urology experts
Latest Videos
Featured Videos

STOCKHOLM, SWEDEN ( - Infection with human papillomavirus (HPV) is a known risk factor for penile cancer (PC) development.

The reported proportion of PC associated with high-risk HPV ranges from 30% to 100%. Given the rising incidence of HPV-associated head and neck squamous cell cancer, Dr. Djajadiningrat and colleagues sought to assess the prevalence of high-risk HPV in a contemporary cohort of patients with PC. PC specimens from 213 patients, treated between 2001 and 2009, were tested for high-risk HPV DNA using PCR. Positive samples were then typed using a reverse line blot assay. Survival rates were calculated and compared based on the presence of high-risk PC.

eauFifty-three men (25%) had high-risk HPV DNA detected in their specimen, with a predominance of subtype 16 (79%). At a median follow-up of 59 months (range 40-68 months), 5-year cancer-specific survival was 82% and 96% in patients with high-risk HPV-negative and positive disease, respectively. As has been previously described, HPV infection is present in a small subset of PC patients, and the prevalence of HPV-associated PC has not increased over the past decade. Further, infection with high-risk HPV (as evidenced by the presence of high-risk HPV DNA) appears to confer a survival advantage for patients with PC.

Presented by R.S. Djajadiningrat at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden

The Netherlands Cancer Institute, Department. of Urology, Amsterdam, Netherlands

Written by Jeffrey J. Tomaszewski, MD, medical writer for


Publications focusing on urological cancer treatments through original commentary & articles
Everyday Urology Volume 3 Issue 2

Everyday Urology™ - Oncology Insights

From the Editor

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor


Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.


Upcoming educational events
October 19-23, 2018 / European Society for Medical Oncology 2018 Congress
European Society for Medical Oncology 2018 Congress
October 19-20, 2018 / Hilton New York JFK Airport Hotel
16th International Conference on Nephrology & Therapeutics
October 19-20, 2018 / Hilton New York JFK Airport Hotel
3rd Annual Kidney Congress